Medicine
-
Choline Deficiency Linked to Anxiety and Brain Chemistry
ISLAMABAD, July 10 — A new look at brain imaging data suggests that people with anxiety disorders may have measurably lower levels…
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
ISLAMABAD, July 10 — Vaccines and immunotherapies are transforming how medicine approaches both prevention and treatment, with a growing body of evidence…
-
Human Immune System: How It Defends the Body Against Pathogens,
WASHINGTON, July 10 — The human immune system operates as a coordinated network of cells, tissues, and organs that defends the body…
-
Aubrey de Grey: Radical Life Extension via Damage Repair
LONDON, July 10 — Aubrey de Grey, the British biomedical gerontologist whose radical vision of defeating aging has made him a polarizing…
-
Alzheimer’s Drug Lecanemab Slows Cognitive Decline 27% in Trial
MANILA, July 10 — For millions of families across Asia and around the world, the shadow of Alzheimer’s disease has long been…
-
Katalin Karikó’s mRNA research wins 2023 Nobel Prize
LONDON, July 10 — The detail that matters in the story of Katalin Karikó is not the Nobel Prize, nor the 95%…
-
Decades of mRNA Research Led to Fastest Vaccines by 2020
ROME, July 10 — The story of messenger RNA vaccines begins not in a pandemic, but in a laboratory mouse. In 1990,…
-
Nobel Laureate Dr. James Allison’s CTLA-4 discovery launched immunotherapy
HOUSTON, July 10 — The man who taught the immune system to fight cancer has spent the better part of three decades…
-
Queen Mary team’s brush swab detects oral cancer in under an hour
LONDON, July 8 — Against the backdrop of a global struggle to catch cancer early, researchers at Queen Mary University of London…
-
Senolytics: Clearing Senescent Cells to Combat Age-Related Disease
ROCHESTER, Minnesota, July 8 — For a field that began with a single question about aging cells, senolytic research has come a…
-
Metformin and Rapamycin: Two Anti-Aging Drug Candidates With Very Different Evidence
NEW YORK, July 8 — The calculus around aging research is shifting. Two drugs, one a decades-old diabetes staple and the other…
-
Alzheimer’s in America: 6.9 million patients and $360 billion in care costs in 2024
WASHINGTON, July 8 — The numbers arrive with the cold weight of an epidemic that refuses to recede. By 2024, an estimated…
-
How Jonas Salk’s 1954 Field Trial With 1.8 Million Children Led to the Polio Vaccine
NEW YORK, July 8 — 1.8 million children. That is the figure that matters from the 1954 field trial of Jonas Salk’s…
-
Pasteur’s 1881 Anthrax Vaccine Trial Was a Public Test, but the Vaccine Was Not What He Claimed
PARIS, July 8 — The mechanics of how a 19th-century chemist reshaped modern medicine are worth dissecting, because the story is less…
-
FDA Approves Breyanzi CAR-T Therapy for Relapsed Chronic Lymphocytic Leukemia
MANILA, July 7 — For families across the region watching loved ones battle blood cancers that keep returning, a new treatment option…
-
Rye pollen compounds’ structures unlocked after decades for cancer research
CHICAGO, July 7 — Nearly 30 years ago, researchers discovered two unusual molecules in rye pollen that appeared to slow tumor growth…
-
UK Phase 2 Trial Opens to Test CY-101 in Rare Adrenal Cancer
LONDON, July 5 — A new immunotherapy drug is entering clinical trials for patients with a rare and aggressive adrenal gland cancer…
-
ETH Zurich Builds Light-Controlled Switch That Wakes Dormant Lung Cancer Cells in the Lab
One number sits at the center of this new cancer research: the glucocorticoid receptor. It is a single protein. It is the…
-
US Cancer Survival Rose From 49% to 69% Since 1975, but Gains Are Uneven
NEW YORK, July 5 — For families facing a cancer diagnosis, the language of treatment can feel like a foreign country. Words…
-
Oncologist warns breast cancer signs go beyond a lump
LONDON, July 3 — Actress and presenter Lisa Faulkner has revealed she underwent surgery for early-stage breast cancer, a diagnosis she said…
-
Vitamin B12 compound shows promise against deadly brain cancer
BOSTON — A modified form of vitamin B12, designed to deliver nitric oxide directly to tumors, has shown promise in early animal…
-
Zenocutuzumab Gives Rare NRG1-Positive Bile Duct Cancer Patients a First Targeted Option
For the small group of patients whose bile duct cancer is driven by a specific genetic glitch, the standard treatment has been…
-
Florida A&M researchers test new drug class targeting previously untreatable pancreatic cancer
For decades, the KRAS gene was considered untouchable. A single mutation in this gene drives rapid cell division in pancreatic ductal adenocarcinoma,…
-
NHS urges Britons to check moles for ABCDE melanoma signs this summer
Britons with moles are being told to look for five specific changes this summer. The NHS posted a checklist on social media…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992